Azione 002082 WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Wanbangde Pharmaceutical Holding Group Co., Ltd.

Azioni

002082

CNE000001P94

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 20/06/2024 		Variaz. 5gg Var. 1 gen.
4,39 CNY -1,79% Grafico intraday di Wanbangde Pharmaceutical Holding Group Co., Ltd. -4,36% -31,41%
08/05 La FDA statunitense assegna la designazione di farmaco per malattie pediatriche rare alla Huperzina A di Wanbangde Pharmaceutical MT
29/04 Wanbangde Pharmaceutical Holding Group Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023
US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Wanbangde Pharmaceutical Holding Group Co., Ltd. Proposes Final Cash Dividend for the Year 2023
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Wanbangde Pharma Elects Vice Chairman, Appoints CFO
Wanbangde Pharma's Anesthesia Passes Drug Regulator's Consistency Evaluation
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) added to S&P Global BMI Index
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Board Appointments
Wanbangde Pharmaceutical Registers New Medical Device
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Cash Dividend for the Year 2022
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Profit Distribution Proposal for 2022
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) dropped from S&P Global BMI Index
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 002082
  4. Notizie Wanbangde Pharmaceutical Holding Group Co., Ltd.
  5. Altre lingue